How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/extravasation-injury-from-anthracycline-injection.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Extravasation Injury from Anthracycline Injection — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Extravasation Injury from Anthracycline Injection (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Extravasation Injury from Anthracycline Injection, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Zinecard	DEXRAZOXANE	Pfizer	Cytoprotective Agent	DNA topoisomerase 2-alpha		1995-01-01
Zinecard	Zinecard	M.D. Anderson Cancer Center		DNA topoisomerase 2-beta, DNA topoisomerase 2-alpha

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 1 drug in Extravasation Injury from Anthracycline Injection
M.D. Anderson Cancer Center · 1 drug in Extravasation Injury from Anthracycline Injection
Pfizer · 1 drug in Extravasation Injury from Anthracycline Injection

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Extravasation Injury from Anthracycline Injection:

Cite this brief

Drug Landscape (2026). Extravasation Injury from Anthracycline Injection — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/extravasation-injury-from-anthracycline-injection. Accessed 2026-06-10.

Extravasation Injury from Anthracycline Injection full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing